The involvement of TGF-β1 in PF has also been demonstrated in several murine models of PCM, and TGF-β1 has been used as an important parameter in determining the antifibrotic effect of new therapeutic approaches for Paracoccidioides-induced PF [12]. This evidence concerns the gene TGFB1 and paracoccidioidomycosis.